Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Longfellow Healthcare Partners is a private healthcare-focused lower middle market investment firm based in Cambridge, Massachusetts. The firm invests in revenue-generating healthcare businesses rather than drug-development startups, targeting sectors such as pharma and medtech services, digital healthcare, next-generation diagnostics, managed care, and consumer-driven care. Its website emphasizes majority ownership or selective minority investments in profitable companies with established business models. Longfellow appears to function as an investor and operator in healthcare services rather than as a therapeutics developer, so it does not disclose a drug pipeline, molecular targets, or clinical-stage assets. The firm positions itself as a long-term healthcare investment platform inspired by a "mini-Berkshire Hathaway" approach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Longfellow Healthcare Partners.